Jump to Main Content

2023 Highlights of ASH®

Highlights of ASH in Latin America

April 28-29, 2023
WTC Events Center
Av. of the United Nations, 12,551
São Paulo, Brazil

Join the world's leading hematology experts at Highlights of ASH in Latin America, a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and non-malignant hematology.

By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.

Through participation in this meeting, you will be able to:

  • Recap stand-out abstracts from the most recent ASH annual meeting
  • Discuss rapidly evolving developments in hematology and hematology-oncology with leading faculty in the field
  • Participate in interactive panel discussions and attend small group lunch sessions with the experts
  • Improve therapeutic and overall practice methods
  • Discover new treatments for patients

This meeting has been designed to be a rewarding educational event for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists.

Program Co-Host

ASH is proud to co-host this meeting with the Brazilian Association of Hematology, Hemotherapy and Cell Therapy (ABHH).

Register Get email updates

Program Schedule

8:00 a.m. Registration and Exhibition Opens 
8:45 a.m. Welcome and Introductions
9:00 a.m.

Myelodysplastic Syndromes

Amy Dezern, MD 
Johns Hopkins University 
Baltimore, MD

9:30 a.m.

Myeloproliferative Neoplasms Including Chronic Myeloid Leukemia

Mrinal Patnaik, MD 
Mayo Clinic 
Rochester, MN

10:00 a.m.

ITP/TTP, Immune Hemolysis, and aHUS

Sandhya Panch, MD 
Seattle Cancer Care Alliance 
Seattle, WA

10:30 a.m. Panel Discussion
11:00 a.m. Coffee Break and Exhibition
11:30 a.m.

Venous Thromboembolism/Anticoagulation and Its Reversal

Alex Spyropoulos, MD 
Northwell Health 
Manhasset, NY

12:00 p.m.

Special Education Session: VTE Guidelines for Latin America

Suely Rezende, MD
Universidade Federal de Minas Gerais
Belo Horizonte, Brazil

Jaime Pereira, MD
Catholic University of Chile
Santiago, Chile

12:45 p.m. Panel Discussion  
1:15 p.m. Lunch with the Experts Session 
2:30 p.m.

Sickle Cell Disease: Sickling and Other Hemoglobinopathies

Jeffrey Lebensburger, DO
University of Alabama at Birmingham
Birmingham, AL

3:00 p.m.

Hematopoietic Stem Cell Transplantation

Brittany Ragon, MD 
Atrium Health 
Charlotte, NC

3:30 p.m.

Transfusion Medicine and Apheresis

Moritz Stolla, MD, PhD
Bloodworks Northwest
Seattle, WA

4:00 p.m. Panel Discussion 
4:30 p.m. Highlights of ASH Day 1 Program Adjournment 
8:00 a.m. Registration and Exhibition 
8:45 a.m.  Welcome and Introductions  
9:00 a.m.

Disorders of Hemostasis

Marilyn Manco-Johnson, MD
University of Colorado
Denver, Colorado

9:30 a.m.

Acquired Bone Marrow Failure Syndromes

Daria V. Babushok, MD, PHD
University of Pennsylvania
Philadelphia, PA

10:00 a.m.

Special Education Session: Car T-Cell Therapy

Alice Bertaina, MD, PhD 
Stanford University 
Stanford, CA

10:45 a.m. Panel Discussion 
11:15 a.m. Coffee Break and Exhibition 
11:45 a.m.

Chronic Lymphocytic Leukemia

Farrukh Awan, MD 
UT Southwestern 
Dallas, TX

12:15 p.m.


Pamela Allen, MD
Emory University
Atlanta, GA

12:45 p.m. Panel Discussion 
1:15 p.m. Lunch with the Experts Session 
2:30 p.m.

Acute Myeloid Leukemia

Keith Pratz, MD
University of Pennsylvania
Philadelphia, PA

3:00 p.m.

Acute Lymphoblastic Leukemia

Marlise Luskin, MD
Dana-Farber Cancer Institute
Boston, MA

3:30 p.m.

Myeloma & Plasma Cell Dyscrasia

Natalie S. Callander, MD
University of Wisconsin
Madison, WI

4:00 p.m. Panel Discussion 
4:30 p.m. Program Adjournment 

Corporate Support

The American Society of Hematology would like to acknowledge the following companies for the educational grants provided in support of the 2023 Highlights of ASH in Latin America:

  • AstraZeneca
  • Pfizer Inc.